## **Core Concept**
Maternal diabetes during pregnancy is known to increase the risk of various congenital anomalies in the offspring, including chromosomal and cardiac anomalies. The underlying mechanism involves the teratogenic effects of hyperglycemia on embryonic development.

## **Why the Correct Answer is Right**
The correct answer, **Diabetes in pregnancy**, is associated with an increased risk of congenital anomalies, including chromosomal and cardiac anomalies. Hyperglycemia during early pregnancy can disrupt normal embryonic development, leading to an increased risk of structural heart defects, neural tube defects, and chromosomal abnormalities. The exact mechanisms are not fully understood, but it is believed that hyperglycemia induces oxidative stress and disrupts cellular signaling pathways critical for development.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain infections during pregnancy can increase the risk of congenital anomalies, they are not as strongly associated with chromosomal and cardiac anomalies as maternal diabetes.
- **Option B:** Although certain medications can be teratogenic, the question seems to focus on a condition rather than an external exposure like a drug.
- **Option C:** This option is not specified, but based on the context, it seems less directly related to the risk of chromosomal and cardiac anomalies compared to maternal diabetes.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that women with pre-existing diabetes or those who develop gestational diabetes are at an increased risk of having offspring with congenital anomalies. Tight glycemic control before and during early pregnancy is crucial to minimize these risks. A commonly remembered association is that maternal diabetes increases the risk of **congenital heart defects**, particularly **transposition of the great arteries**.

## **Correct Answer:** . **Diabetes in pregnancy**